BASHAN DROR (President & CEO) purchased 42.3% of their position (56K shares) of PROTALIX BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $101.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/23/2025ACC: 0001781450-25-000005
DirectorOfficer· President & CEO
Since Jun 2019
+56K
Net shares
Net buyer
$101.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
56K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+56K
Price / share
$1.81
Trade value
$101.36K
% of position
42.3%
12/19/2025
132.52K→188.52K
Total
Net shares
+56K
Net value
$101.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | P · Purchase | +56K | $1.81 | $101.36K | 42.3% | 132.52K | 188.52K |
| Total | +56K | $101.36K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.34M
Total
2.34M indirect2.34M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.34M | Indirect |
| Total | 2.34M | 2.34M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported